Starten Sie Ihre Suche...


Wir weisen darauf hin, dass wir technisch notwendige Cookies verwenden. Weitere Informationen

Efficient transduction of mature CD83+ dendritic cells using recombinant adenovirus suppressed T cell stimulatory capacity

Gene therapy. Bd. 7. H. 3. London: Nature Publ. Group 2000 S. 249 - 254

Erscheinungsjahr: 2000

ISBN/ISSN: 0969-7128

Publikationstyp: Zeitschriftenaufsatz (Forschungsbericht)

Sprache: Englisch

Doi/URN: 10.1038/sj.gt.3301077

Volltext über DOI/URN

Geprüft:Bibliothek

Inhaltszusammenfassung


We have developed a culture method for the foreign serum-free generation of highly immunostimulatory, CD83+ human dendritic cells (DC). In this study, we evaluated the feasibility and consequences of endogenously expressing antigens in mature DC using adenoviral vectors. Transduction of DC with Ad-EGFP demonstrated endogenous fluorescence in 50-85% of CD83+ DC. Ad-transduced DC stimulated the proliferation of allogeneic CD8+ and CD4+ T cells at low DC: T cell ratios. However, at high DC: T ce...We have developed a culture method for the foreign serum-free generation of highly immunostimulatory, CD83+ human dendritic cells (DC). In this study, we evaluated the feasibility and consequences of endogenously expressing antigens in mature DC using adenoviral vectors. Transduction of DC with Ad-EGFP demonstrated endogenous fluorescence in 50-85% of CD83+ DC. Ad-transduced DC stimulated the proliferation of allogeneic CD8+ and CD4+ T cells at low DC: T cell ratios. However, at high DC: T cell ratios the stimulatory capacity of Ad-transduced DC was suppressed. This immunosuppressive effect was confirmed by demonstrating that the stimulatory function of untreated DC could be suppressed in a dose-dependent manner by addition of Ad-transduced DC. Furthermore, transwell experiments suggested that direct cell contact was required. Taken together, our results demonstrate the feasibility of efficiently expressing antigens in CD83+ DC using adenoviruses. However, immunosuppressive effects must be considered and carefully studied before Ad-transduced DC are employed for clinical trials. Gene Therapy (2000) 7, 249-254.» weiterlesen» einklappen

Autoren


Jonuleit, Helmut (Autor)
Tuting, Thomas (Autor)
Steitz, Julia (Autor)
Bruck, Jürgen (Autor)
Giesecke, Andrea (Autor)
Steinbrink, Kerstin (Autor)
Knop, Jürgen (Autor)
Enk, Alexander H. (Autor)

Klassifikation


DFG Fachgebiet:
2.21 - Mikrobiologie, Virologie und Immunologie

DDC Sachgruppe:
Medizin